Italy Mrna Therapeutics Market Size & Outlook, 2023-2030

The mrna therapeutics market in Italy is expected to reach a projected revenue of US$ 953.1 million by 2030. A compound annual growth rate of 13.7% is expected of Italy mrna therapeutics market from 2024 to 2030.
Revenue, 2023 (US$M)
$386.8
Forecast, 2030 (US$M)
$953.1
CAGR, 2024 - 2030
13.7%
Report Coverage
Italy

Italy mrna therapeutics market highlights

  • The Italy mrna therapeutics market generated a revenue of USD 386.8 million in 2023 and is expected to reach USD 953.1 million by 2030.
  • The Italy market is expected to grow at a CAGR of 13.7% from 2024 to 2030.
  • In terms of segment, infectious diseases was the largest revenue generating application in 2023.
  • Infectious Diseases is the most lucrative application segment registering the fastest growth during the forecast period.


Mrna therapeutics market data book summary

Market revenue in 2023USD 386.8 million
Market revenue in 2030USD 953.1 million
Growth rate13.7% (CAGR from 2023 to 2030)
Largest segmentInfectious diseases
Fastest growing segmentInfectious Diseases
Historical data2021 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInfectious Diseases
Key market players worldwideModerna Inc, BioNTech SE ADR, CureVac NV Ordinary Shares, Arcturus Therapeutics Holdings Inc, Sanofi SA, GSK PLC, Pfizer Inc, AstraZeneca PLC, Argos Therapeutics, ETHRIS


Other key industry trends

  • In terms of revenue, Italy accounted for 3.3% of the global mrna therapeutics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany mrna therapeutics market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 1,883.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

MRNA Therapeutics Market Scope

Mrna therapeutics market segmentation & scope
Infectious Diseases
Oncology
Rare Genetic Diseases
Respiratory Diseases
Others
Prophylactic
Therapeutic
Hospitals & Clinics
Research Organizations
Others

MRNA Therapeutics Market Companies

Name Profile # Employees HQ Website

Italy mrna therapeutics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics market will help companies and investors design strategic landscapes.


Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Italy mrna therapeutics market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.


The strong presence of well-established and emerging product manufacturers and continuous organic & inorganic growth strategies they adopt are expected to create a lucrative environment for market growth.

For instance, in April 2021, the Italy government held talks with several manufacturers of mRNA-based vaccines, including Novartis AG and Moderna, Inc., to start domestic production of mRNA-based vaccines in Italy. Such initiatives are expected to drive the mRNA therapeutics market in the country over the forecast period.

Reasons to subscribe to Italy mrna therapeutics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Italy mrna therapeutics market databook

  • Our clientele includes a mix of mrna therapeutics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Italy mrna therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into Italy mrna therapeutics market from 2021 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Italy mrna therapeutics market size, by application, 2021-2030 (US$M)

Italy MRNA Therapeutics Market Outlook Share, 2023 & 2030 (US$M)

Italy mrna therapeutics market size, by application, 2021-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more